SS
KPRX icon

SBI Securities’s Kiora Pharmaceuticals KPRX Stock Holding History

SBI Securities’s Portfolio KPRX Stock Details KPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$494 Hold
256
– – ﹤0.01% 2897
2025
Q4 		$504 Hold
256
– – ﹤0.01% 2878
2025
Q3 		$712 Hold
256
– – ﹤0.01% 2828
2025
Q2 		$737 Hold
256
– – ﹤0.01% 2809
2025
Q1 		$771 Buy
256
+255
+25,500% +$885 ﹤0.01% 2696
2024
Q4 		$3 Buy
+1
New +$3 ﹤0.01% 4038

Other funds holding KPRX

ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
RC
Rangeley Capital New Canaan, Connecticut $103M AUM 77.32% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

SBI Securities's KPRX Position: Q1 2026 in Review

SBI Securities held its Kiora Pharmaceuticals (KPRX) position steady in Q1 2026 at 256 shares worth $494. The position accounts for ﹤0.01% of the portfolio, ranked #2897.

SBI Securities first reported a position in KPRX in Q4 2024 and has held it in 6 quarters since. The position peaked at $771 in Q1 2025. 18 funds tracked by Wall St. Rank hold KPRX as of Q1 2026.

  • SBI Securities held 256 shares of Kiora Pharmaceuticals worth $494 as of Q1 2026.
  • SBI Securities left its Kiora Pharmaceuticals share count unchanged in Q1 2026.
  • Kiora Pharmaceuticals made up ﹤0.01% of SBI Securities's portfolio in Q1 2026, its #2897 holding.
  • SBI Securities first reported a position in Kiora Pharmaceuticals in Q4 2024 and has held it in 6 quarters since.
  • SBI Securities's Kiora Pharmaceuticals position peaked at $771 in Q1 2025.
  • 18 funds tracked by Wall St. Rank held Kiora Pharmaceuticals as of Q1 2026.

Based on SBI Securities's 13F filing for Q1 2026, filed 28 Apr 2026.